---
schema_version: "secwatch.filing_event.v1"
accession: "0001612630-26-000063"
form_type: "8-K"
ticker: "JYNT"
cik: "0001612630"
company_name: "JOINT Corp"
filed_at: "2026-08-06T20:04:29+00:00"
generated_at: "2026-08-06T20:06:58.420613+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Joint Corp Q2 revenue up 14% to $15.2M; net income $653K; refranchising substantially complete

## Summary
- Revenue $15.2M (+14% YoY); consolidated net income $653K vs $93K; adjusted EBITDA from continuing ops $1.5M vs $88K.
- Free cash flow $1.9M vs $364K; cash from operations $2.2M (+152% YoY).
- Refranchising substantially complete; now operates as capital-light pure-play franchisor with 941 clinics (896 franchised, 45 company-owned).
- Repurchased 82,000 shares for $677K at avg $8.23; $3.8M remaining under $12M buyback program.
- Reiterated 2026 guidance: system-wide sales $519-552M, comp sales (3)% to 3%, consolidated Adj. EBITDA $12.5-13.5M.

## SEC filing metadata
- accession: 0001612630-26-000063
- form_type: 8-K
- ticker: JYNT
- cik: 0001612630
- company_name: JOINT Corp
- filed_at: 2026-08-06T20:04:29+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1612630/000161263026000063/0001612630-26-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1612630/000161263026000063/jynt-20260806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001612630-26-000063
- JSON: https://secwatch.observer/filing/0001612630-26-000063.json
- Plain text: https://secwatch.observer/filing/0001612630-26-000063.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
